Maegim

Stock search

Search by company name, 6-digit code, or Korean initials (e.g. ㅅㅅㅈㅈ)

☆한국어

WOOREE BIO CO., LTD

우리바이오082850KOSDAQSector: Food, Beverage & Tobacco
₩8970.00%Market cap ₩43.5BAs of Sep 1, 2026 close · updated once daily
Market cap
₩43.5B
#1214 in KOSDAQ
Loss
PER not computable
0.21x
Sector median 0.54x
1.0%
Sector median 1.4%
Trading halted — grade display suspended

This stock is under a trading halt per KRX disclosure. Grade display resumes once trading resumes.

See withholding criteria →View source filing (DART) ↗

This grade is not a buy/sell recommendation — it is information mechanically scored from public data using a fixed formula.

1-year closing price

Loading closing price history…
 
Low ₩859High ₩2,470
Latest close
Price change by period
1W
0.00%
1M
1.80%
3M
43.20%
1Y
61.00%

As of the Sep 1, 2026 close · updated once daily · a factual record computed from closing prices only; dividends are not included, and this is not a buy or sell signal.

1

Financial strength

25.7/100
How much debt does it carry relative to equity?
191.5%
Sector median 85.0%
Sector lowhighBottom 13.5% in sector
Can it cover what's due within a year?
126.0%
Sector median 133.1%
Sector lowhighBottom 48.8% in sector
How much of revenue becomes profit?
0.1%
Sector median 4.2%
Sector lowhighBottom 17.1% in sector
How much did it earn on its own capital?
-4.6%
Sector median 4.0%
Sector lowhighBottom 23.2% in sector

Source filing: annual report (consolidated) — view original ↗

2

Growth momentum

10.5/100
How much did revenue grow in a year?
-15.6%
Sector median 1.5%
Sector lowhighBottom 7% in sector
Has it grown steadily over three years?
-8.3%
Sector median 2.2%
Sector lowhighBottom 11.3% in sector
Did core profits grow in a year?
-93.7%
Sector median -4.3%
Sector lowhighBottom 10.8% in sector
Are core profits higher than three years ago?
-97.2%
Sector median 20.1%
Sector lowhighBottom 12.7% in sector

Financial trend

Revenue

Growth & margin

Revenue growth Operating margin

Year over year — alongside the sector median

This stock Sector median

A factual chart of confirmed annual results from annual reports — the same source as the grading indicators. Not a buy or sell signal.

Source filing: annual report (consolidated) — view original ↗

3

Price attractiveness

55.4/100
Is the price expensive relative to earnings?
Loss-making (P/E not computable)
Sector median P/E of profitable peers 9.7x · 32% loss-making
Sector lowhighBottom 12.5% in sector
Is the price expensive relative to book value?
0.21x
Sector median 0.54x
Sector lowhighTop 1.8% in sector

Valuation uses the Sep 1, 2026 close and market cap

4

Shareholder Return

Single-indicator axis45.3/100
Does the company actually pay dividends?
1.0%
Sector median 1.4%
Sector lowhighBottom 45.3% in sector

Dividend per share (annual)

Cash dividend per common share as stated in annual reports. ₩0 means no dividend that year.

Dividends & treasury shares

Total cash dividends (FY2025)
₩944M
Treasury shares (FY2025)
1,249,200 shares (2.5% of shares issued)

Source: annual report (DART) — dividend allocation & total shares

Source filing: annual report (consolidated) — view original ↗

Financial checklist

Based on the FY2025 annual report · year-over-year comparison · determined on Sep 1, 2026

Of 9 items: 3 met · 6 not met · 0 not computable

Not metMetNot computable

Positive net income
Whether net income (attributable to owners where available) is above zero.
Not met
-₩9.4B
Positive operating cash flow
Whether cash flow from operations is above zero.
Met
₩34.8B
Return on assets up
Whether net income over beginning total assets rose from the prior year.
Not met
0.8% → -1.5%
Operating cash flow exceeds net income
Whether operating cash flow is greater than net income.
Met
₩34.8B vs -₩9.4B
Liabilities-to-assets ratio down
Whether total liabilities as a share of total assets fell from the prior year.
Not met
55.9% → 65.7%
Current ratio up
Whether current assets over current liabilities rose from the prior year.
Not met
144.3% → 126.0%
Shares outstanding not increased
Whether common shares issued did not increase from the prior year. Increases from bonus issues and stock dividends are also counted.
Met
48,456,578 → 48,456,578
Operating margin up
Whether operating income over revenue rose from the prior year.
Not met
1.2% → 0.1%
Asset turnover up
Whether revenue over beginning total assets rose from the prior year.
Not met
2.11x → 1.71x

A record of facts determined by fixed rules from the financial statements in the latest annual report. Not used in grading, and not a buy or sell signal. Source filing: annual report (consolidated) — view original ↗

Grade change history

Jul 23, 2026D

Methodology version change (v2.0 applied)

Jul 15, 2026DVersion v1

First calculation

Grade changes are a factual record produced from public data by a fixed formula; they do not signal future changes.

Disclosure & financial badges

Factual records determined from public filings and periodic reports by fixed rules — not buy/sell signals.

Negative-evidence group (dilution, loss, dispute)Mixed interpretationPositive-evidence group (shareholder return)Dots classify the disclosure type by the direction of research evidence — not an assessment or investment judgment about this company.

Disclosure event history

Corporate value-up plan filed

Filed a “기업가치제고계획(자율공시)” (corporate value-up plan, voluntary disclosure) (filed 2026-04-21). View filing ↗

Determined as of 2026-09-01

Recent filings for this stock

Last 120 days · monitored filing types only
Periodic report filedAug 14, 2026Source ↗
Periodic report filedMay 15, 2026Source ↗

View in the filings calendar →